This page lists all changes to TDSG-CB 203 after Release 02. This page constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.
Changes introduced with Release 03
A change was made to the version control definitions and all Issue numbering information removed.
Bleeding Disorder See Change Notification No. 18 - 2007
Changes introduced with Release 04
Tamiflu® (oseltamivir) See Change Notification No. 30 - 2009
Relenza® (zanamivir) See Change Notification No. 31 - 2009
Changes introduced with Release 05
Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009
Changes introduced with Release 06
Body Piercing See Change Notification No. 02 - 2010
Endoscopy See Change Notification No. 03 - 2010
Inoculation Injury See Change Notification No. 04 - 2010
Changes introduced with Release 07
West Nile Virus (WNV) See Change Notification No. 09 - 2010
Changes introduced with Release 08
Infertility See Change Notification No. 08 - 2011
Sexually Transmitted Disease See Change Notification No. 09 - 2011
Changes introduced with Release 09
West Nile Virus See
Change Notification No. 11 - 2011
Changes introduced with Release 10
Porphyria See
Change Notification No. 20 - 2011
Changes introduced with Release 11
XMRVSee Change Notification No. 25 - 2011
Hepatitis CSee Change Notification No. 27 - 2011
Changes introduced with Release 12
West Nile Virus (WNV)See Change Notification No. 05 - 2012
Changes introduced with Release 13
AcneSee Change Notification No. 15 - 2012
PsoriasisSee Change Notification No. 17 - 2012
ToxoplasmosisSee Change Notification No. 18 - 2012
Changes introduced with Release 13 Issue 02
Fertility treatment: entry replaced by link to infertility
